Features
- Drug : Sirolimus
- Drug coating thickness < 4μm
- Stent strut width : < 90μm
- 70 µm thin struts : < 70μm
- Nominal Pressure : 9atm(2.25~3.50mm) / 10atm(3.75~4.00mm)
- Rated Burst Pressure : 16atm(2.25~3.50mm) / 14atm(3.75~4.00mm)
Clinical outcomes at 5 years
|
GENOSS DES (n=38) |
B Company(n=39) |
P value |
| MACE |
2(5.3%) |
5(12.8%) |
0.431 |
| Death |
2(5.3%) |
4(10.3%) |
0.675 |
| Cardiac |
0 |
1(2.6%) |
|
| Noncardiac |
2(5.3%) |
3(7.7%) |
|
| MI |
0 |
0 |
1.000 |
| TLR |
1(2.6%) |
1(2.6%) |
1.000 |
| TVR |
3(7.9%) |
1(2.6%) |
0.358 |
| Stent thrombosis |
0 |
0 |
1.000 |
MACE = major adverse cardiac events, MI = myocardial infarction, TLR = target lesion revascularization, TVR = target vessel revascularization.
Sirolimus Release Profile
Model Name
| Stent Diamiter(mm) |
8 |
13 |
18 |
23 |
28 |
33 |
38 |
| 2.25 |
GDES-08-225 |
GDES-13-225 |
GDES-18-225 |
GDES-23-225 |
GDES-28-225 |
GDES-33-225 |
GDES-38-225 |
| 2.50 |
GDES-08-250 |
GDES-13-250 |
GDES-18-250 |
GDES-23-250 |
GDES-28-250 |
GDES-33-250 |
GDES-38-250 |
| 2.75 |
GDES-08-275 |
GDES-13-275 |
GDES-18-275 |
GDES-23-275 |
GDES-28-275 |
GDES-33-275 |
GDES-38-275 |
| 3.00 |
GDES-08-300 |
GDES-13-300 |
GDES-18-300 |
GDES-23-300 |
GDES-28-300 |
GDES-33-300 |
GDES-38-300 |
| 3.25 |
GDES-08-325 |
GDES-13-325 |
GDES-18-325 |
GDES-23-325 |
GDES-28-325 |
GDES-33-325 |
GDES-38-325 |
| 3.50 |
GDES-08-350 |
GDES-13-350 |
GDES-18-350 |
GDES-23-350 |
GDES-28-350 |
GDES-33-350 |
GDES-38-350 |
| 3.75 |
GDES-08-375 |
GDES-13-375 |
GDES-18-375 |
GDES-23-375 |
GDES-28-375 |
GDES-33-375 |
GDES-38-375 |
| 4.00 |
GDES-08-400 |
GDES-13-400 |
GDES-18-400 |
GDES-23-400 |
GDES-28-400 |
GDES-33-400 |
GDES-38-400 |
